Literature DB >> 8108444

Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells.

S Garfinkel1, S Brown, J H Wessendorf, T Maciag.   

Abstract

Human umbilical vein endothelial cell (HUVEC) senescence in vitro is characterized by the loss of proliferative potential and an increase in cell size. Because HUVEC senescence in one strain (H101) has been characterized by the increase in the steady-state mRNA level for the signal-peptideless cytokine, interleukin (IL) 1 alpha, we have examined young and senescent populations of five additional HUVEC strains (H3605, H103, H928, H929, and H930) to determine whether the elevated levels of IL-1 alpha mRNA could be observed in all HUVEC strains. Consistent with the data from strain H101, strains H3605 and H930 also exhibited a low steady-state level of the IL-1 alpha mRNA in young populations compared to elevated levels of IL-1 alpha mRNA in the senescent populations. However, three strains (H103, H928, and H929) did not exhibit reduced levels of IL-1 alpha mRNA in the young populations, and interestingly, strain H928, at times, expressed relatively high IL-1 alpha mRNA levels in the young populations. In addition, expression of the steady-state level of plasminogen activator inhibitor 1 and cyclooxygenase 2 was elevated in senescent populations of all HUVEC strains examined, whereas young populations exhibited a low level of expression for these genes regardless of the IL-1 alpha mRNA level. Further, the level of the IL-1 alpha polypeptide was elevated in senescent HUVEC populations relative to young populations that expressed either a high or low level of the IL-1 alpha mRNA. We have also demonstrated that the elevated level of IL-1 alpha mRNA in the senescent population of strain H3605 may be regulated by mRNA stability; however, this mechanism does not apply to all the HUVEC strains examined in this study. Thus, we suggest that while mRNA levels of the IL-1-response genes for plasminogen activator inhibitor 1 and cyclooxygenase 2 are appropriate markers for HUVEC senescence, HUVEC strain-specific post-transcriptional mechanisms may exist to regulate the function of IL-1 alpha as a modifier of HUVEC senescence in vitro.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108444      PMCID: PMC43199          DOI: 10.1073/pnas.91.4.1559

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  RNA abundance measured by a lysate RNase protection assay.

Authors:  D S Haines; D H Gillespie
Journal:  Biotechniques       Date:  1992-05       Impact factor: 1.993

2.  Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing.

Authors:  D J Herzyk; J N Allen; C B Marsh; M D Wewers
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

3.  The serial cultivation of human diploid cell strains.

Authors:  L HAYFLICK; P S MOORHEAD
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

4.  Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts.

Authors:  S Kumar; A J Millis; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Tumor necrosis factor increases stability of interleukin-1 mRNA by activating protein kinase C.

Authors:  M Gorospe; S Kumar; C Baglioni
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

6.  Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor.

Authors:  J H Wessendorf; S Garfinkel; X Zhan; S Brown; T Maciag
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

7.  AU RNA-binding factors differ in their binding specificities and affinities.

Authors:  P R Bohjanen; B Petryniak; C H June; C B Thompson; T Lindsten
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

8.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

Authors:  D A Jones; D P Carlton; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

9.  Regulation of human tissue factor expression by mRNA turnover.

Authors:  S M Ahern; T Miyata; J E Sadler
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Interleukin-1 alpha mediates an alternative pathway for the antiproliferative action of poly(I.C) on human endothelial cells.

Authors:  S Garfinkel; D S Haines; S Brown; J Wessendorf; D H Gillespie; T Maciag
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

View more
  18 in total

1.  Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1.

Authors:  J Y Hsu; M Y Hsu; T Sorger; M Herlyn; E M Levine
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

2.  Gene expression profiling of replicative and induced senescence.

Authors:  Maggie Purcell; Adele Kruger; Michael A Tainsky
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

3.  Excess centrosomes induce p53-dependent senescence without DNA damage in endothelial cells.

Authors:  Zhixian Yu; Dana L Ruter; Erich J Kushner; Victoria L Bautch
Journal:  FASEB J       Date:  2017-06-16       Impact factor: 5.191

4.  Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium.

Authors:  Edward Chaum; Christina S Winborn; Sujoy Bhattacharya
Journal:  Mamm Genome       Date:  2015-05-12       Impact factor: 2.957

5.  Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing.

Authors:  C Heymes; A Habib; D Yang; E Mathieu; F Marotte; J Samuel; C M Boulanger
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling.

Authors:  Fabiola Olivieri; Raffaella Lazzarini; Rina Recchioni; Fiorella Marcheselli; Maria Rita Rippo; Silvia Di Nuzzo; Maria Cristina Albertini; Laura Graciotti; Lucia Babini; Serena Mariotti; Giorgio Spada; Angela Marie Abbatecola; Roberto Antonicelli; Claudio Franceschi; Antonio Domenico Procopio
Journal:  Age (Dordr)       Date:  2012-06-13

Review 7.  Senescent cells as a source of inflammatory factors for tumor progression.

Authors:  Albert R Davalos; Jean-Philippe Coppe; Judith Campisi; Pierre-Yves Desprez
Journal:  Cancer Metastasis Rev       Date:  2010-06       Impact factor: 9.264

8.  Redox control of the senescence regulator interleukin-1α and the secretory phenotype.

Authors:  Donald A McCarthy; Ryan R Clark; Toni R Bartling; Mohamed Trebak; J Andres Melendez
Journal:  J Biol Chem       Date:  2013-09-23       Impact factor: 5.157

Review 9.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

10.  Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network.

Authors:  Arturo V Orjalo; Dipa Bhaumik; Bridget K Gengler; Gary K Scott; Judith Campisi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.